Protein misfolding and retinal degeneration

Cold Spring Harbor Perspectives in Biology

Volumn 3, Issue 11, 2011, Pages

  Tzekov, Radouil ^a   Stein, Linda ^a   Kausha, Shaleshl ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EYE PROTEIN; RHODOPSIN;

ALZHEIMER DISEASE; CHEMISTRY; GENETICS; HOMEOSTASIS; HUMAN; METABOLISM; PARKINSON DISEASE; PHYSIOLOGY; PROTEIN FOLDING; RETINA DEGENERATION; REVIEW;

ALZHEIMER DISEASE; EYE PROTEINS; HOMEOSTASIS; HUMANS; PARKINSON DISEASE; PROTEIN FOLDING; RETINAL DEGENERATION; RHODOPSIN;

EID: 84861738428     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a007492     Document Type: Article

References (67)

1. Allikmets R, Singh N, Sun H, Shroyer NF, Hutchinson A, Chidambaram A, Gerrard B, Baird L, Stauffer D, Peiffer A, et al. 1997. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 15: 236-246.
2. Archibald NK, Clarke MP, Mosimann UP, Burn DJ. 2009. The retina in Parkinson's disease. Brain 132: 1128-1145.
3. Bernales S, Papa FR, Walter P. 2006. Intracellular signaling by the unfolded protein response. Annu Rev Cell Dev Biol 22: 487-508.
4. Berson EL, Rosner B, Sandberg MA, Dryja TP. 1991. Ocular findings in patients with autosomal dominant retinitis pigmentosa and a rhodopsin gene defect (Pro-23-His). Arch Ophthalmol 109: 92-101.
5. Berson EL, Rosner B, Sandberg MA, Hayes KC, Nicholson BW, Weigel-DiFranco C, Willett W. 1993. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 111: 761-772.
6. Birch DG, Anderson JL, Fish GE. 1999. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy. Ophthalmology 106: 258-268.
7. Blanks JC, Torigoe Y, Hinton DR, Blanks RH. 1996. Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging 17: 377-384.
8. Bowes C, Li T, Danciger M, Baxter LC, Applebury ML, Farber DB. 1990. Retinal degeneration in the rd mouse is caused by a defect in the β subunit of rod cGMPphosphodiesterase. Nature 347: 677-680.
9. Burgess R, Millar ID, Leroy BP, Urquhart JE, Fearon IM, De Baere E, Brown PD, Robson AG, Wright GA, Kestelyn P, et al. 2008. Biallelic mutation of BEST1 causes a distinct retinopathy in humans. Am J Hum Genet 82: 19-31.
10. Clemson CM, Tzekov R, Krebs M, Checchi JM, Bigelow C, Kaushal S. 2011. Therapeutic potential of valproic acid for retinitis pigmentosa. Br J Ophthalmol 95: 89-93.
11. Cremers FP, van de Pol DJ, van Driel M, den Hollander AI, van Haren FJ, Knoers NV, Tijmes N, Bergen AA, Rohrschneider K, Blankenagel A, et al. 1998. Autosomal recessive retinitis pigmentosa and cone-rod dystrophy caused by splice site mutations in the Stargardt's disease gene ABCR. Hum Mol Genet 7: 355-362.
12. Curcio CA, Drucker DN. 1993. Retinal ganglion cells in Alzheimer's disease and aging. Ann Neurol 33: 248-257.
13. Doh SH, Kim JH, Lee KM, Park HY, Park CK. 2010. Retinal ganglion cell death induced by endoplasmic reticulum stress in a chronic glaucoma model. Brain Res 1308: 158-166.
14. Fu L, Garland D, Yang Z, Shukla D, Rajendran A, Pearson E, Stone EM, Zhang K, Pierce EA. 2007. The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice. Hum Mol Genet 16: 2411-2422.
15. Gorbatyuk MS, Knox T, LaVail MM, Gorbatyuk OS, Noorwez SM, Hauswirth WW, Lin JH, Muzyczka N, Lewin AS. 2010. Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP /Grp78. Proc Natl Acad Sci 107: 5961-5966.
16. Guo L, Salt TE, Luong V, Wood N, Cheung W, Maass A, Ferrari G, Russo-Marie F, Sillito AM, Cheetham ME, et al. 2007. Targeting amyloid-β in glaucoma treatment. Proc Natl Acad Sci 104: 13444-13449.
17. Hardy J, Allsop D. 1991. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 12: 383-388.
18. Hargrave PA. 2001. Rhodopsin structure, function, and topography-the Friedenwald lecture. Invest Ophthalmol Vis Sci 42: 3-9.
19. Hebert DN, Molinari M. 2007. In and out of the ER: Protein folding, quality control, degradation, and related human diseases. Physiol Rev 87: 1377-1408.
20. Karan G, Yang Z, Zhang K. 2004. Expression of wild type and mutant ELOVL4 in cell culture: Subcellular localization and cell viability. Mol Vis 10: 248-253.
21. Karan G, Lillo C, Yang Z, Cameron DJ, Locke KG, Zhao Y, Thirumalaichary S, Li C, Birch DG, Vollmer-Snarr HR, et al. 2005a. Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: A model for macular degeneration. Proc Natl Acad Sci 102: 4164-4169.
22. Karan G, Yang Z, Howes K, Zhao Y, Chen Y, Cameron DJ, Lin Y, Pearson E, Zhang K. 2005b. Loss of ER retention and sequestration of the wild-type ELOVL4 by Stargardt disease dominant negative mutants. Mol Vis 11: 657-664.
23. Katz B, Rimmer S, Iragui V, Katzman R. 1989. Abnormal pattern electroretinogram in Alzheimer's disease: Evidence for retinal ganglion cell degeneration? Ann Neurol 26: 221-225.
24. Kaushal S, Khorana HG. 1994. Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry 33: 6121-6128.
25. Kaushal S, Ridge KD, Khorana HG. 1994. Structure and function in rhodopsin: The role of asparagine-linked glycosylation. Proc Natl Acad Sci 91: 4024-4028.
26. Krebs MP, Noorwez SM, Malhotra R, Kaushal S. 2004. Quality control of integral membrane proteins. Trends Biochem Sci 29: 648-655.
27. Krebs MP, Holden DC, Joshi P, Clark CLIII, Lee AH, Kaushal S. 2010. Molecular mechanisms of rhodopsin retinitis pigmentosa and the efficacy of pharmacological rescue. J Mol Biol 395: 1063-1078.
28. Leonard KC, Petrin D, Coupland SG, Baker AN, Leonard BC, LaCasse EC, Hauswirth WW, Korneluk RG, Tsilfidis C. 2007. XIAP protection of photoreceptors in animal models of retinitis pigmentosa. PLoS One 2: e314.
29. Lin JH, Li H, Yasumura D, Cohen HR, Zhang C, Panning B, Shokat KM, Lavail MM, Walter P. 2007. IRE1 signaling affects cell fate during the unfolded protein response. Science 318: 944-949.
30. Marmorstein AD, Marmorstein LY, Rayborn M, Wang X, Hollyfield JG, Petrukhin K. 2000. Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium. Proc Natl Acad Sci 97: 12758-12763.
31. Marmorstein LY, McLaughlin PJ, Peachey NS, Sasaki T, Marmorstein AD. 2007. Formation and progression of sSub-retinal pigment epithelium deposits in efemp1 mutation knock-in mice: A model for the early pathogenic course of macular degeneration. Hum Mol Genet 16: 2423-2432.
32. +/2 mice: Implications for involvement of ABCR in age-related macular degeneration. Invest Ophthalmol Vis Sci 42: 1685-1690.
33. Mendes HF, van der Spuy J, Chapple JP, Cheetham ME. 2005. Mechanisms of cell death in rhodopsin retinitis pigmentosa: Implications for therapy. Trends Mol Med 11: 177-185.
34. Mendes CS, Levet C, Chatelain G, Dourlen P, Fouillet A, Dichtel-Danjoy ML, Gambis A, Ryoo HD, Steller H, Mollereau B. 2009. ER stress protects from retinal degeneration. EMBO J 28: 1296-1307.
35. Michaelides M, Johnson S, Poulson A, Bradshaw K, Bellmann C, Hunt DM, Moore AT. 2003. An autosomal dominant bull's-eye macular dystrophy (MCDR2) that maps to the short arm of chromosome 4. Invest Ophthalmol Vis Sci 44: 1657-1662.
36. Milenkovic VM, Rivera A, Horling F, Weber BH. 2007. Insertion and topology of normal and mutant bestrophin-1 in the endoplasmic reticulum membrane. J Biol Chem 282: 1313-1321.
37. Morimoto T, Fujikado T, Choi JS, Kanda H, Miyoshi T, Fukuda Y, Tano Y. 2007. Transcorneal electrical stimulation promotes the survival of photoreceptors and preserves retinal function in royal college of surgeons rats. Invest Ophthalmol Vis Sci 48: 4725-4732.
38. Moritz OL, Tam BM. 2010. Recent insights into the mechanisms underlying light-dependent retinal degeneration from x. Laevis models of retinitis pigmentosa. Adv Exp Med Biol 664: 509-515.
39. Nathans J, Davenport CM, Maumenee IH, Lewis RA, Hejtmancik JF, Litt M, Lovrien E, Weleber R, Bachynski B, Zwas F. 1989. Molecular genetics of human blue cone monochromacy. Science 245: 831-838.
40. Noorwez SM, Kuksa V, Imanishi Y, Zhu L, Filipek S, Palczewski K, Kaushal S. 2003. Pharmacological chaperone-mediated in vivo folding and stabilization of the P23H-opsin mutant associated with autosomal dominant retinitis pigmentosa. J Biol Chem 278: 14442-14450.
41. Noorwez SM, Malhotra R, McDowell JH, Smith KA, Krebs MP, Kaushal S. 2004. Retinoids assist the cellular folding of the autosomal dominant retinitis pigmentosa opsin mutant P23H. J Biol Chem 279: 16278-16284.
42. Noorwez SM, Sama RR, Kaushal S. 2009. Calnexin improves the folding efficiency of mutant rhodopsin in the presence of pharmacological chaperone 11-cis-retinal. J Biol Chem 284: 33333-333342.
43. Paquet C, Boissonnot M, Roger F, Dighiero P, Gil R, Hugon J. 2007. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 420: 97-99.
44. Parisi V, Restuccia R, Fattapposta F, Mina C, Bucci MG, Pierelli F. 2001. Morphological and functional retinal impairment in Alzheimer's disease patients. Clin Neurophysiol 112: 1860-1867.
45. Prager TC, Schweitzer FC, Peacock LW, Garcia CA. 1993. The effect of optical defocus on the pattern electroretinogram in normal subjects and patients with Alzheimer's disease. Am J Ophthalmol 116: 363-369.
46. Roy K, Stein L, Kaushal S. 2010. Ocular gene therapy: An evaluation of recombinant adeno-associated virusmediated gene therapy interventions for the treatment of ocular disease. Hum Gene Ther 21: 1-13.
47. Roybal CN, Marmorstein LY, Vander Jagt DL, Abcouwer SF. 2005. Aberrant accumulation of fibulin-3 in the endoplasmic reticulum leads to activation of the unfolded protein response and VEGF expression. Invest Ophthalmol Vis Sci 46: 3973-3979.
48. Sartucci F, Borghetti D, Bocci T, Murri L, Orsini P, Porciatti V, Origlia N, Domenici L. 2010. Dysfunction of the magnocellular stream in Alzheimer's disease evaluated by pattern electroretinograms and visual evoked potentials. Brain Res Bull 82: 169-176.
49. Sauer CG, Gehrig A, Warneke-Wittstock R, Marquardt A, Ewing CC, Gibson A, Lorenz B, Jurklies B, Weber BH. 1997. Positional cloning of the gene associated with X-linked juvenile retinoschisis. Nat Genet 17: 164-170.
50. Schröder M, Kaufman RJ. 2005. The mammalian unfolded protein response. Annu Rev Biochem 74: 739-789.
51. Schulz JB. 2007. Mechanisms of neurodegeneration in idiopathic Parkinson's disease. Parkinsonism Relat D 13 (Suppl 3): S306-S308.
52. Shinohara T, Mulhern ML, Madson CJ. 2008. Silencing gene therapy for mutant membrane, secretory, and lipid proteins in retinitis pigmentosa (RP). Med Hypotheses 70: 378-380.
53. Sohocki MM, Daiger SP, Bowne SJ, Rodriquez JA, Northrup H, Heckenlively JR, Birch DG, Mintz-Hittner H, Ruiz RS, Lewis RA, et al. 2001. Prevalence of mutations causing retinitis pigmentosa and other inherited retinopathies. Hum Mutat 17: 42-51.
54. Stone EM, Lotery AJ, Munier FL, Héon E, Piguet B, Guymer RH, Vandenburgh K, Cousin P, Nishimura D, Swiderski RE, et al. 1999. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet 22: 199-202.
55. Strenn K, Dal-Bianco P, Weghaupt H, Koch G, Vass C, Gottlob I. 1991. Pattern electroretinogram and luminance electroretinogram in Alzheimer's disease. J Neural Transm Suppl 33: 73-80.
56. Surgechev A, Surgechev A. 2010. Conformational diseases: Looking into the eyes. Brain Res Bull 81: 12-24.
57. Szegezdi E, Logue SE, Gorman AM, Samali A. 2006. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 7: 880-885.
58. Tam BM, Moritz OL. 2006. Characterization of rhodopsin P23H-induced retinal degeneration in a Xenopus laevis model of retinitis pigmentosa. Invest Ophthalmol Vis Sci 47: 3234-3241.
59. Trick GL, Barris MC, Bickler-Bluth M. 1989. Abnormal pattern electroretinograms in patients with senile dementia of the Alzheimer type. Ann Neurol 26: 226-231.
60. Wang X, Nookala S, Narayanan C, Giorgianni F, Beranova-Giorgianni S, McCollum G, Gerling I, Penn JS, Jablonski MM. 2009. Proteomic analysis of the retina: Removal of RPE alters outer segment assembly and retinal protein expression. Glia 57: 380-392.
61. Weng J, Mata NL, Azarian SM, Tzekov RT, Birch DG, Travis GH. 1999. Insights into the function of Rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice. Cell 98: 13-23.
62. Wiszniewski W, Zaremba CM, Yatsenko AN, Jamrich M, Wensel TG, Lewis RA, Lupski JR. 2005. ABCA4 mutations causing mislocalization are found frequently in patients with severe retinal dystrophies. Hum Mol Genet 14: 2769-2778.
63. Wu WW, Molday RS. 2003. Defective discoidin domain structure, subunit assembly, and endoplasmic reticulum processing of retinoschisin are primary mechanisms responsible for X-linked retinoschisis. J Biol Chem 278: 28139-28146.
64. Yang LP, Wu LM, Guo XJ, Tso MO. 2007. Activation of endoplasmic reticulum stress in degenerating photoreceptors of the rd1 mouse. Invest Ophthalmol Vis Sci 48: 5191-5198.
65. Yang Z, Chen Y, Lillo C, Chien J, Yu Z, Michaelides M, Klein M, Howes KA, Li Y, Kaminoh Y, et al. 2008. Mutant prominin 1 found in patients with macular degeneration disrupts photoreceptor disk morphogenesis in mice. J Clin Invest 118: 2908-2916.
66. Young RW. 1971. The renewal of rod and cone outer segments in the rhesus monkey. J Cell Biol 1: 303-318.
67. Zhang K, Kniazeva M, Han M, Li W, Yu Z, Yang Z, Li Y, Metzker ML, Allikmets R, Zack DJ, et al. 2001. A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat Genet 27: 89-93.